Speech-Language Pathologists in Adrian, MI Accepting Medicare

25 Speech-Language Pathologists found. Showing 21 - 25

Clair Hoffman, M.A. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1325 N Main St Ste H, Adrian, MI 49221 Phone: 517-759-7902    Fax: 517-759-4223

Ashley Porter Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1325 N Main St Ste H, Adrian, MI 49221 Phone: 517-759-7902

Rachel Laura Richmond, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1424 S Main St, Adrian, MI 49221 Phone: 517-312-1712

Erica Kenner, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1325 N Main St, Adrian, MI 49221 Phone: 517-759-7902

Monica Garrison, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 Corporate Dr, Adrian, MI 49221 Phone: 517-264-2790

News Archive

Cordis commences enrollment in safety trial of INCRAFT stent graft system for AAA

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technologies, announced today that the first patients have been enrolled in the INNOVATION trial, which will assess the safety of a new stent graft system, called INCRAFT™, to treat abdominal aortic aneurysm (AAA). An estimated 27 million people worldwide have abdominal aortic aneurysms.

Robin Hood releases Poverty Tracker survey results

Today, Robin Hood announced the release of the Poverty Tracker survey results, developed in partnership with Columbia University's Population Research Center. This quarterly survey of 2,300 households throughout the five boroughs and across all income levels is designed to take a deeper, more realistic look at disadvantage among New Yorkers.

Human embryonic stem cells show potential in treating rats with Parkinson's symptoms

Brain cells derived from human embryonic stem cells improved the condition of rats with Parkinson's-like symptoms dramatically, but the treatment caused a significant problem - the appearance of brain tumors - that scientists are now working to solve.

Encision completes private placement of 1,500,000 shares of common stock

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, announced today that it had completed a private placement of 1,500,000 shares of its common stock.

St. Luke's Episcopal Hospital, UH College of Pharmacy earn national 'best practices' award

With antibiotic resistance on the rise worldwide, health care professionals are continually seeking to optimize how they combat drug-resistant infections.

Read more Medical News

› Verified 2 days ago

• 1
• 2(current)